Vicapsys Life Sciences Stock Fundamentals
| VICP Stock | USD 7.00 0.00 0.00% |
Vicapsys Life Sciences fundamentals help investors to digest information that contributes to Vicapsys Life's financial success or failures. It also enables traders to predict the movement of Vicapsys Pink Sheet. The fundamental analysis module provides a way to measure Vicapsys Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vicapsys Life pink sheet.
Vicapsys |
Vicapsys Life Sciences Company Return On Equity Analysis
Vicapsys Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vicapsys Life Return On Equity | -10.59 |
Most of Vicapsys Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vicapsys Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vicapsys Life Sciences has a Return On Equity of -10.5916. This is 55.81% lower than that of the Healthcare sector and 70.95% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Vicapsys Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vicapsys Life's current stock value. Our valuation model uses many indicators to compare Vicapsys Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vicapsys Life competition to find correlations between indicators driving Vicapsys Life's intrinsic value. More Info.Vicapsys Life Sciences is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vicapsys Life's earnings, one of the primary drivers of an investment's value.Vicapsys Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vicapsys Life's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vicapsys Life could also be used in its relative valuation, which is a method of valuing Vicapsys Life by comparing valuation metrics of similar companies.Vicapsys Life is currently under evaluation in return on equity category among its peers.
Vicapsys Fundamentals
| Return On Equity | -10.59 | |||
| Return On Asset | -0.8 | |||
| Current Valuation | 31.17 M | |||
| Shares Outstanding | 31.19 M | |||
| Shares Owned By Insiders | 45.87 % | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0 X | |||
| EBITDA | (734.42 K) | |||
| Net Income | (765.84 K) | |||
| Cash And Equivalents | 17.29 K | |||
| Debt To Equity | 285.70 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (262.9 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | -4.44 | |||
| Market Capitalization | 31.19 M | |||
| Total Asset | 404.12 K | |||
| Z Score | -3.3 | |||
| Net Asset | 404.12 K |
About Vicapsys Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vicapsys Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vicapsys Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vicapsys Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia. Vicapsys Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Pair Trading with Vicapsys Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vicapsys Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicapsys Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Vicapsys Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vicapsys Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vicapsys Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vicapsys Life Sciences to buy it.
The correlation of Vicapsys Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vicapsys Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vicapsys Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vicapsys Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vicapsys Pink Sheet Analysis
When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.